Core Insights - Borregaard reported an increase in operating revenues to NOK 2,036 million in Q1 2025, up from NOK 1,975 million in the same quarter last year [1] - EBITDA rose to NOK 511 million, compared to NOK 442 million in the previous year [1] - Profit before tax increased to NOK 319 million from NOK 261 million year-over-year [2] BioSolutions Performance - BioSolutions achieved an all-time high result, driven primarily by strong sales to the agriculture sector [2][3] - The specialization strategy of the company has shown resilience in challenging macroeconomic conditions, which is expected to be a key driver for future success [3] BioMaterials and Fine Chemicals Performance - For BioMaterials, higher sales prices were countered by lower sales volumes and increased costs, including wood costs [2] - Fine Chemicals experienced a weaker result primarily due to lower sales prices for bioethanol [2] Earnings Per Share - Earnings per share increased to NOK 2.52, up from NOK 2.01 in the corresponding quarter last year [2]